Search
Phio Pharmaceuticals Corp
PHIOAdd to Watchlist
0.860USD
-0.003-0.35%
Close 10-30 16:00（ET）
9.99MMarket Cap
LossP/E TTM
Phio Pharmaceuticals Corp (PHIO) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Phio Pharmaceuticals Corp in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
14.000USD+1427.05%
PHIO Analyst Recommendation Trends
In the current month, PHIO has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PHIO average Analyst price target in the last month is 14.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
PHIO Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
11
8
0
0
23
Financial Forecasting
Based on analysts' estimates, PHIO EPS is projected to reach -0.360 in FY2026Q3, following reported EPS of -0.356 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.34
-0.23
-0.36
-0.36
-0.39
Actual
-0.25
-0.34
-0.36
--
--
Surprise
+25.49%
-46.63%
+1.06%
--
--
FAQs
What is Phio Pharmaceuticals Corp's price target?
Analysts forecast that Phio Pharmaceuticals Corp's price target is USD 14.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 14.00.
How have Phio Pharmaceuticals CorpPHIO's recent earnings per share performed?
The market expectation was USD -0.36, while Phio Pharmaceuticals CorpPHIO's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.36.
What is the analyst rating for Phio Pharmaceuticals Corp?
Based on the ratings of Phio Pharmaceuticals Corp's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.